Total Funding
51
72
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68277
Transgene is a biotechnology company that designs and develops innovative immunotherapies.
- Thibaut du Fayet: VP Corporate Development, Alliances & Programs Management
- James Wentworth: Chief Business OfficerPast Role: Adaptimmune, Director, Business Development and Strategy
About the Company
Transgene is an integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Their expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.
